InvestorsHub Logo
Followers 5
Posts 359
Boards Moderated 0
Alias Born 01/10/2019

Re: Blueheel1 post# 40186

Monday, 04/29/2019 12:16:45 PM

Monday, April 29, 2019 12:16:45 PM

Post# of 232963
Well, Fortuno made a sensible argument: further dilution at .40 won't get us anywhere which changes the situation of the company fundamentally, since we will hardly get enough money for commercialisation with dilution at these levels.

This needs to be addressed differently than by saying "move on/stop bitching". Obviously, if a decent deal is closed till the SP meeting, we will be fine, but who knows? Personally, I expect that such a deal will be closed by then, but I'm not so sure anymore. After all, it hasn't been excluded by Nader that the 100m shares will be used in the near-term.

And again: the monotherapy protocol was promised for last week at the latest. Where is it? It is beyond my understanding why Nader would again miss a self-imposed deadline... From the CEO of a public company in a crucial stage of its development I expect a clear communication strategy:
TNBC "any day now" => If timeline has changed, explain why?
Monotherapy protocol "this week or next week" => If not, why?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News